Profile data is unavailable for this security.
About the company
BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. It is advancing two cell therapy platforms derived from bone marrow such as CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being advanced as a cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS). Its autologous CardiAMP and allogeneic CardiALLO cell therapies intended for cardiac indications of HFrEF and CMI are enabled by its Helix minimally invasive intramyocardial therapeutic delivery platform.
- Revenue in USD (TTM)71.00k
- Net income in USD-7.72m
- Incorporated1994
- Employees16.00
- LocationBioCardia Inc320 Soquel WaySUNNYVALE 94085United StatesUSA
- Phone+1 (650) 226-0123
- Fax+1 (650) 631-3731
- Websitehttps://www.biocardia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| StimCell Enegetics Inc | 0.00 | -124.17k | 8.92m | 0.00 | -- | -- | -- | -- | -0.0155 | -0.0155 | 0.00 | -- | 0.00 | -- | -- | -- | -299.64 | -703.78 | -- | -- | -- | 84.03 | -- | -2,996.54 | -- | -6.02 | -- | -- | -100.00 | -- | 71.22 | -- | -- | -- |
| Biomx Inc | 0.00 | -8.71m | 8.94m | 58.00 | 1.88 | 0.4644 | -- | -- | 0.2614 | 0.2614 | 0.00 | 2.08 | 0.00 | -- | -- | 0.00 | -18.71 | -- | -24.42 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.59 | -- | -- | -- |
| Jaguar Health Inc | 10.48m | -37.74m | 9.10m | 49.00 | -- | 0.7539 | -- | 0.8683 | -19.89 | -19.89 | 2.76 | 1.54 | 0.2018 | 0.231 | 7.17 | 213,877.50 | -73.81 | -95.29 | -106.50 | -163.54 | 80.10 | 67.28 | -365.71 | -522.28 | 1.36 | -3.22 | 0.6802 | -- | -18.36 | 17.19 | 12.97 | -- | -- | -- |
| Yubo International Biotech Ltd | 25.78k | -2.00m | 9.71m | 18.00 | -- | -- | -- | 376.47 | -0.0167 | -0.0167 | 0.0002 | -0.0261 | 0.0145 | 0.0467 | 0.1935 | 1,432.22 | -120.65 | -- | -- | -- | 80.41 | -- | -8,325.41 | -- | 0.1598 | -17,544.82 | -- | -- | 479.86 | -- | 0.8224 | -- | -- | -- |
| Senti Biosciences Inc | 0.00 | -70.87m | 9.71m | 48.00 | -- | 0.608 | -- | -- | -15.59 | -15.60 | 0.00 | 3.49 | 0.00 | -- | -- | 0.00 | -74.80 | -- | -83.22 | -- | -- | -- | -- | -- | -- | -- | 0.0064 | -- | -40.25 | -- | -67.94 | -- | -- | -- |
| BioCardia Inc | 71.00k | -7.72m | 9.79m | 16.00 | -- | 3.51 | -- | 137.85 | -4.22 | -4.22 | 0.036 | 0.6086 | 0.0142 | -- | 1.25 | 4,437.50 | -154.22 | -107.34 | -401.77 | -154.17 | -- | -- | -10,876.06 | -1,779.24 | -- | -- | 0.00 | -- | -64.72 | -5.26 | 2.82 | -- | -28.89 | -- |
| Kiora Pharmaceuticals Inc | 16.02m | 5.55m | 9.93m | 12.00 | 5.41 | 0.3308 | 1.78 | 0.62 | -0.5993 | -0.5993 | 4.89 | 10.01 | 0.5889 | -- | 9.18 | 1,335,000.00 | 20.40 | -70.52 | 22.75 | -81.86 | -- | -- | 34.64 | -2,040.61 | -- | -- | 0.00 | -- | -- | -- | 3.97 | -- | -- | -- |
| BioRestorative Therapies Inc | 377.00k | -6.17m | 10.00m | 11.00 | -- | 1.00 | -- | 26.52 | -0.7135 | -0.7135 | 0.0546 | 1.44 | 0.0266 | -- | 3.69 | 34,272.73 | -43.49 | -192.11 | -53.99 | -329.32 | 79.04 | -- | -1,636.79 | -19,116.15 | -- | -- | 0.00 | -- | 21.70 | 5.61 | 43.67 | -- | 67.77 | -- |
| Imunon Inc | 0.00 | -19.45m | 10.05m | 33.00 | -- | 1.23 | -- | -- | -1.89 | -1.89 | 0.00 | 0.5649 | 0.00 | -- | -- | 0.00 | -99.63 | -50.18 | -137.53 | -60.27 | -- | -- | -- | -5,725.88 | -- | -- | 0.00 | -- | -100.00 | -- | 45.64 | -- | 26.69 | -- |
| Vaccinex Inc | 388.00k | -18.58m | 10.06m | 37.00 | -- | -- | -- | 25.93 | -12.15 | -12.15 | 0.2512 | -0.5081 | 0.1047 | -- | 0.4046 | 10,486.49 | -501.27 | -262.29 | -- | -- | -- | -- | -4,787.89 | -4,257.17 | -- | -49.48 | -- | -- | 107.27 | -4.67 | -2.20 | -- | -22.20 | -- |
| Dominari Holdings Inc | 12.59m | -22.69m | 10.23m | 26.00 | -- | 0.2673 | -- | 0.8126 | -3.85 | -3.85 | 2.11 | 6.10 | 0.2361 | -- | 3.80 | 484,192.30 | -42.55 | -26.82 | -44.27 | -27.45 | -- | -- | -180.22 | -3,353.52 | -- | -4.83 | 0.00 | -- | -- | 135.75 | 12.72 | -- | 63.99 | -- |
| Oncotelic Therapeutics Inc | 0.00 | -4.66m | 10.31m | 22.00 | -- | 1.17 | -- | -- | -0.0115 | -0.0115 | 0.00 | 0.0217 | 0.00 | -- | -- | 0.00 | -17.29 | -25.03 | -39.98 | -48.76 | -- | -- | -- | -1,692.93 | -- | -0.5009 | 0.614 | -- | -- | -- | -255.12 | -- | -- | -- |
| ELEVAI Labs Inc | 2.45m | -5.47m | 10.46m | 18.00 | -- | 0.1166 | -- | 4.27 | -0.2924 | -0.2924 | 0.1303 | 0.1733 | 0.3826 | 0.9499 | 216.67 | 135,897.80 | -85.53 | -- | -121.34 | -- | 71.15 | -- | -223.57 | -- | 3.40 | -- | 0.00 | -- | 123.50 | -- | -138.94 | -- | -- | -- |
| CeCors Inc | -100.00bn | -100.00bn | 10.46m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| Indaptus Therapeutics Inc | 0.00 | -14.89m | 10.66m | 7.00 | -- | 1.77 | -- | -- | -1.72 | -1.72 | 0.00 | 0.5887 | 0.00 | -- | -- | 0.00 | -114.42 | -66.55 | -138.96 | -81.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.68 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to BioCardia Inc's reporting currency: US Dollar USD
2.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Susquehanna Financial Group LLLPas of 30 Sep 2024 | 70.60k | 2.02% |
| Geode Capital Management LLCas of 30 Sep 2024 | 14.74k | 0.42% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 12.62k | 0.36% |
| Tower Research Capital LLCas of 30 Sep 2024 | 1.28k | 0.04% |
| Pingora Partners LLCas of 30 Sep 2024 | 1.04k | 0.03% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Sep 2024 | 435.00 | 0.01% |
| Global Retirement Partners LLCas of 30 Sep 2024 | 411.00 | 0.01% |
| Vanguard Global Advisers LLCas of 30 Sep 2024 | 268.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2024 | 61.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2024 | 30.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
